Kamada Ltd SEC filings KMDA
Kamada Ltd has 538 filings in SEC EDGAR's recent list, going back to Jan 24, 2013. Its latest annual report, Form 20-F, was filed on Mar 11, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| F-3 | Shelf registration (foreign issuer) | Sep 9, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 11, 2023 | — |
| S-8 | Employee stock plan registration | Jun 28, 2022 | — |
| S-8 | Employee stock plan registration | Aug 14, 2019 | — |
| S-8 | Employee stock plan registration | Feb 6, 2018 | — |
| 424B5 | Prospectus supplement | Aug 1, 2017 | — |
| 424B5 | Prospectus supplement | Jul 27, 2017 | — |
| F-3/A | Filing | Jul 13, 2017 | — |
| S-8 | Employee stock plan registration | Feb 9, 2017 | — |
| F-3 | Shelf registration (foreign issuer) | Nov 28, 2016 | — |
| S-8 | Employee stock plan registration | Nov 10, 2015 | — |
| S-8 | Employee stock plan registration | Dec 9, 2013 | — |
| 424B4 | Prospectus | May 31, 2013 | — |
| F-1/A | Amendment no. 2 to form f-1 | May 28, 2013 | — |
| FWP | Free writing prospectus | May 16, 2013 | — |
| F-1/A | Amendment no. 1 to form f-1 | May 15, 2013 | — |
| F-1 | Registration statement (foreign issuer) | Apr 11, 2013 | — |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KMDA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Rehovot, Israel
- SEC filer status
- Accelerated filer
- SEC CIK
- 1567529
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.